Bara L, Combe-Tamzali S, Conard J, Horellou M H, Samama M
Laboratoire Central d'Hématologie, Hôtel-Dieu, Paris.
J Mal Vasc. 1987;12 Suppl B:78-84.
Activities of anti-Xaam, anti-IIaam, Heptest and calcium thrombin time (Ca TT) were compared in: 12 male healthy volunteers after increasing doses of 20, 40, 60 and 80 mg/day of Enoxaparine; 76 patients after gynecological surgery treated with 20 mg (12 cases), 40 mg (15 cases) or 60 mg (10 cases) per day of Enoxaparine versus calcium heparin as 5,000 IU x 3/day (39 cases); 68 patients after general surgery treated with 2,500 units Fragmine/day (34 cases) versus calcium heparin 5,000 IU x 2/day (34 cases); 27 patients in a medical ward treated with either 7,500 Choay Institute units/day of Fraxiparine (14 cases) or Cutheparine (magnesium heparinate) (13 cases). In this latter case results of Heptest only are reported. In healthy volunteers and patients after gynecological operations, the Ca TT and anti-IIaam activity were significantly modified after doses greater than or equal to 40 mg. Values for anti-Xaam and anti-IIaam were dose-related but higher in healthy volunteers. The anti-Xa/anti-IIa ratio was 3-4. Correlation between Heptest, a simple test, and anti-Xa activity--both very good markers of low molecular weight heparins (LMWH)--was very good (r = 0.93, p less than 0.02 in healthy volunteers; r = 0.87, p less than 0.01 in operated patients). Peak activity was at about 3 to 4 hours after injection, the half-life of anti-Xa and anti-IIa activities being 4 and 2 hours respectively. After heparin injection, the anti-Xa/anti-IIa ratio was 1 but activities were weak (5,000 IU x 2 = 0.02 +/- 0.02), a little higher with 5,000 IU x 3 (0.05 +/- 0.04).(ABSTRACT TRUNCATED AT 250 WORDS)
比较了抗Xa活性、抗IIa活性、希普试验(Heptest)和钙凝血酶时间(Ca TT)在以下几组中的情况:12名男性健康志愿者,接受递增剂量(每日20、40、60和80毫克)的依诺肝素;76名妇科手术后患者,分别接受每日20毫克(12例)、40毫克(15例)或60毫克(10例)的依诺肝素治疗,与每日5000国际单位×3次的钙肝素治疗(39例)进行对比;68名普通外科手术后患者,分别接受每日2500单位弗拉明(Fragmine)治疗(34例)与每日5000国际单位×2次的钙肝素治疗(34例);27名内科病房患者,分别接受每日7500乔艾研究所单位的速避凝(Fraxiparine)治疗(14例)或可塞灵(Cutheparine,肝素镁)治疗(13例)。在后一种情况下,仅报告了希普试验的结果。在健康志愿者和妇科手术后患者中,剂量大于或等于40毫克后,Ca TT和抗IIa活性有显著改变。抗Xa活性和抗IIa活性的值与剂量相关,但在健康志愿者中更高。抗Xa/抗IIa比值为3至4。希普试验(一种简单的检测方法)与抗Xa活性之间的相关性很好,这两者都是低分子肝素(LMWH)的良好标志物(在健康志愿者中r = 0.93,p < 0.02;在手术患者中r = 0.87,p < 0.01)。峰值活性在注射后约3至4小时出现,抗Xa和抗IIa活性的半衰期分别为4小时和2小时。注射肝素后,抗Xa/抗IIa比值为1,但活性较弱(5000国际单位×2 = 0.02 ± 0.02),5000国际单位×3时略高(0.05 ± 0.04)。(摘要截取自250字)